Noteworthy, when used in the same dose-range, BPC 157 counteracts all of the concomitant gastrointestinal lesions, induced by haloperidol, vesicles depletor reserpine, or neurotoxin affecting substantia nigra 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropropyridine (MPTP) (10, 11, 16)
The honest framing is that no validated human dosing protocol exists because no human trials have been done
For the complete clinical framework on how we start first-time peptide patients, including the body composition workup that drives protocol selection, see our complete medical clinic guide to how Perfect B starts a first-time peptide patient with an Inbody scan and a 12-week protocol
The FDA Just Banned 17 Peptide Treatments The agency banned peptides from certain pharmacies, but others blazed past new regulations